Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BioMarin Pharmaceutical Inc.
About BMRN
BioMarin Pharmaceutical Inc. is a global biotechnology company engaged in the development of genetic discovery into medicines that make an impact on the life of each patient. The Company has a portfolio of commercial therapies and a clinical and preclinical pipeline. Its commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. Galafold (migalastat) is its oral treatment for Fabry disease, and Pombiliti (cipaglucosidase alfa-atga) + Opfolda (miglustat), is a two-component therapy for Pompe disease. Its portfolio also includes ALE1, an oral small molecule for the potential treatment of hypophosphatasia (HPP), a rare genetic bone disease caused by mutations in the ALPL gene.
Find out what a historical investment in BioMarin Pharmaceutical Inc. would be worth today using our BMRN stock calculator.
Market Capitalisation
$12.60B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
4.46M
High today
$65.29
Low today
$63.84
Open price
$65.25
52-week high
$70.98
52-week low
$49.26
Ready to start your investing journey with Stake?
Open an accountHow do I buy BMRN shares in Australia?
Buying BMRN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BioMarin Pharmaceutical Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BMRN
What is the ticker symbol of BioMarin Pharmaceutical Inc.?
The ticker symbol for BioMarin Pharmaceutical Inc. is BMRN.
How much is one share of BMRN?
One share of BMRN is valued at $64.24 as of 18 September 2026.
What is the market capitalisation of BioMarin Pharmaceutical Inc. BMRN?
As of 18 September 2026 BioMarin Pharmaceutical Inc. has a market cap of $12.60B.
What is the P/E ratio of BMRN?
The Price to Earnings ratio of BMRN is 175.45.
What is the Earnings Per Share of BMRN?
The Earnings Per Share of BMRN is $0.37.
What is the 52-week high for BioMarin Pharmaceutical Inc. stock?
The BioMarin Pharmaceutical Inc. 52-week high stock price is $70.98.
What is the 52-week low for BioMarin Pharmaceutical Inc. stock?
The BioMarin Pharmaceutical Inc. 52-week low stock price is $49.26.
Can I buy BMRN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BMRN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BMRN on Stake
- Buy BMRN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BMRN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BMRN related stocks